DXC vs STE · P/E 7.6, rev $12.87B vs P/E 25, rev $5.46B
DXC Technology Co (DXC) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
DXC Technology Co (DXC) is a information technology services company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported DXC revenue for 2025-03-31 was $12.87B. Net income was $396.0M. Revenue was down 5.8% from 2024-03-31 to 2025-03-31. DXC currently screens at market cap $2.92B and trailing P/E 7.6.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
DXC currently screens at market cap $2.92B and trailing P/E 7.6. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the DXC and STE stock pages for the full models.
Not investment advice.